Abstract
Relapsing polychondritis (RP) is a rare disorder, often requiring high doses of immunosuppressive therapy to control its potentially life-threatening consequences. The advent of biological agents has added to the armamentarium available to treat RP, but the lack of controlled trials, along with the small numbers of patients and disease heterogeneity means that new therapies are prescribed without the benefits of rigorous clinical research. Thus, information on individual cases is of value in expanding our knowledge of the use of biologic agents in rare conditions. We report on the use of rituximab in a patient who subsequently developed catastrophic aortic incompetence, and we review the literature in relation to the use of this drug in RP.
This is a preview of subscription content, log in via an institution to check access.
References
Dib C, Moustafa SE, Mookadam M, Zehr KJ, Michet CJ, Mookadam F (2006) Surgical treatment of the cardiac manifestations of relapsing polychondritis. Mayo Clin Proc 81:772–776
Lang-Lazdunski L, Hvass U, Paillole C, Pansard Y, Langlois J (1995) Cardiac valve replacement in relapsing polychondritis: a review. J Heart Valve Dis 4:227–235
Marshall DA, Jackson R, Rae AP, Capell HA (1992) Early aortic valve cusp rupture in relapsing polychondritis. Ann Rheum Dis 51:413–415
Bowness P, Hawley IC, Morris T, Dearden A, Walport MJ (1991) Complete heart block and severe aortic incompetence in relapsing polychondritis: clinicopathologic findings. Arthritis Rheum 34:97–100
Buckley LM, Ades PA (1992) Progressive aortic valve inflammation occurring despite apparent remission of relapsing polychondritis. Arthritis Rheum 35:812–814
Gergely P, Poor G (2004) Relapsing polychondritis. Best Pract Res Clin Rheumatol 18:723–738
Stabler T, Piette JC, Chevalier X, Marini-Portugal A, Kraus VB (2004) Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 50:3663–3667
Leroux G, Costedoat-Chalumeau N, Brihaye B, Cohen-Bittan J, Amoura Z, Haroche J et al (2009) Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients. Arthritis Rheum 61:577–582
Ratzinger G, Kuen-Spiegl M, Sepp N (2009) Successful treatment of recalcitrant relapsing polychondritis with monoclonal antibodies. J Eur Acad Dermatol Venereol 23:474–475
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McCarthy, E.M., Cunnane, G. Treatment of relapsing polychondritis in the era of biological agents. Rheumatol Int 30, 827–828 (2010). https://doi.org/10.1007/s00296-009-1308-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1308-6